Aptevo Therapeutics Inc [NASDAQ: APVO] price surged by 16.05 percent to reach at $0.04.
The one-year APVO stock forecast points to a potential upside of 96.38. The average equity rating for APVO stock is currently 1.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guru’s Opinion on Aptevo Therapeutics Inc [APVO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for APVO shares is $8.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on APVO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Aptevo Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 05, 2018. While these analysts kept the previous recommendation, Piper Jaffray raised their target price to Overweight. The new note on the price target was released on October 05, 2017, representing the official price target for Aptevo Therapeutics Inc stock.
The Average True Range (ATR) for Aptevo Therapeutics Inc is set at 0.05 The Price to Book ratio for the last quarter was 1.12, with the Price to Cash per share for the same quarter was set at 0.42.
APVO Stock Performance Analysis:
Aptevo Therapeutics Inc [APVO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 19.44. With this latest performance, APVO shares dropped by -17.99% in over the last four-week period, additionally sinking by -61.38% over the last 6 months – not to mention a drop of -96.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APVO stock in for the last two-week period is set at 56.43, with the RSI for the last a single of trading hit 59.26, and the three-weeks RSI is set at 54.05 for Aptevo Therapeutics Inc [APVO]. The present Moving Average for the last 50 days of trading for this stock 0.2233, while it was recorded at 0.2415 for the last single week of trading, and 1.5451 for the last 200 days.
Insight into Aptevo Therapeutics Inc Fundamentals:
Aptevo Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.70 and a Current Ratio set at 1.70.
APVO Stock EPS
With the latest financial reports released by the company, Aptevo Therapeutics Inc posted -6.46/share EPS, while the average EPS was predicted by analysts to be reported at -18.04/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 11.58. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for APVO.
Aptevo Therapeutics Inc [APVO] Institutonal Ownership Details
There are presently around $6.80%, or 6.80%% of APVO stock, in the hands of institutional investors.
